- Patent Title: Aerosol fluoroquinolone formulations for improved pharmacokinetics
-
Application No.: US15132122Application Date: 2016-04-18
-
Publication No.: US09717738B2Publication Date: 2017-08-01
- Inventor: David C. Griffith , Michael N. Dudley , Mark W. Surber , Keith A. Bostian , Olga Rodny
- Applicant: Raptor Pharmaceuticals Inc.
- Applicant Address: US IL Lake Forest
- Assignee: Horizon Orphan LLC
- Current Assignee: Horizon Orphan LLC
- Current Assignee Address: US IL Lake Forest
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: A61K31/397
- IPC: A61K31/397 ; A61K31/535 ; A61P11/06 ; A61K31/5383 ; A61K9/00 ; A61K31/4375 ; A61K31/47 ; A61K31/538 ; A61K47/02 ; A61K31/536
Abstract:
The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to the use of aerosolized fluoroquinolones formulated with divalent or trivalent cations and having improved pulmonary availability for the treatment and management of bacterial infections of the lung and upper respiratory tract.
Public/Granted literature
- US20160287606A1 AEROSOL FLUOROQUINOLONE FORMULATIONS FOR IMPROVED PHARMACOKINETICS Public/Granted day:2016-10-06
Information query
